BBOT to Participate in the Jefferies Global Healthcare Conference in London

Core Viewpoint - BridgeBio Oncology Therapeutics, Inc. (BBOT) is actively engaging in the healthcare sector by participating in the Jefferies Global Healthcare Conference, highlighting its focus on RAS-pathway malignancies [1] Company Overview - BBOT is a clinical-stage biopharmaceutical company that is developing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Kα malignancies [3] - The company's objective is to improve outcomes for patients with cancers driven by the two most prevalent oncogenes in human tumors [3] Event Participation - Members of BBOT's leadership team will present at the Jefferies Global Healthcare Conference on November 17 at 2:30 p.m. GMT [1] - A live webcast of the presentation will be available on the BBOT website, with a replay accessible for at least 90 days post-event [2]